Ogsiveo
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
2023-11-28 15:54:36
by
Dan McCue
WASHINGTON — The Food and Drug Administration on Tuesday approved Ogsiveo tablets for adult patients with progressing desmoid tumors, a rare subtype of soft tissue sarcomas. Desmoid tumors are non-cancerous but can be locally aggressive, invading surrounding structures and organs,... Read More
Straight From The Well
